Evidence map›Paper›PMID 38733294›Full record

ReviewThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society2024

New Insights in ATP Synthesis as Therapeutic Target in Cancer and Angiogenic Ocular Diseases.

Cornelis J F van Noorden, Bahar Yetkin-Arik, Paola Serrano Martinez, Noëlle Bakker, Mathilda E van Breest Smallenburg, Reinier O Schlingemann, Ingeborg Klaassen, Bernarda Majc, Anamarija Habic, Urban Bogataj and 6 more

Abstract readReview
In one paragraph

Review in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Real-Time Visualization of Endogenous HChemical & biomedical imaging · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Cornelis J F van NoordenDepartment of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia.ORCID 0000-0002-6191-0505
Bahar Yetkin-ArikDepartment of Pediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0002-6986-0004
Paola Serrano MartinezOcular Angiogenesis Group, Amsterdam University Medical Center Location University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-0688-0083
Noëlle BakkerOcular Angiogenesis Group, Amsterdam University Medical Center Location University of Amsterdam, Amsterdam, The Netherlands.
Mathilda E van Breest SmallenburgOcular Angiogenesis Group, Amsterdam University Medical Center Location University of Amsterdam, Amsterdam, The Netherlands.
Reinier O SchlingemannOcular Angiogenesis Group, Amsterdam University Medical Center Location University of Amsterdam, Amsterdam, The Netherlands.
Ingeborg KlaassenOcular Angiogenesis Group, Amsterdam University Medical Center Location University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0003-1695-9403
Bernarda MajcDepartment of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia.
Anamarija HabicDepartment of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia.
Urban BogatajBiotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia.
S Katrin GalunDepartment of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia.
Milos VittoriBiotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia.
Mateja Erdani KreftInstitute of Cell Biology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Metka NovakDepartment of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia.
Barbara BreznikDepartment of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia.ORCID 0000-0003-0247-5811
Vashendriya V V HiraDepartment of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lactate and ATP formation by aerobic glycolysis, the Warburg effect, is considered a hallmark of cancer. During angiogenesis in non-cancerous tissue, proliferating stalk endothelial cells (ECs) also produce lactate and ATP by aerobic glycolysis. In fact, all proliferating cells, both non-cancer and cancer cells, need lactate for the biosynthesis of building blocks for cell growth and tissue expansion. Moreover, both non-proliferating cancer stem cells in tumors and leader tip ECs during angiogenesis rely on glycolysis for pyruvate production, which is used for ATP synthesis in mitochondria through oxidative phosphorylation (OXPHOS). Therefore, aerobic glycolysis is not a specific hallmark of cancer but rather a hallmark of proliferating cells and limits its utility in cancer therapy. However, local treatment of angiogenic eye conditions with inhibitors of glycolysis may be a safe therapeutic option that warrants experimental investigation. Most types of cells in the eye such as photoreceptors and pericytes use OXPHOS for ATP production, whereas proliferating angiogenic stalk ECs rely on glycolysis for lactate and ATP production.

Indexed as

Adenosine TriphosphateNeoplasmsNeovascularization, PathologicAnimalsEye DiseasesGlycolysisHumansOxidative PhosphorylationAdenosine Triphosphateaerobic glycolysisanaerobic glycolysisangiogenesisATP synthesiscancer cellscancer stem cellsendothelial cellsenergy metabolismeye diseasesoxidative phosphorylationpericytesretinaWarburg effect

Identifiers

PMID38733294
PMCPMC11107438

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.